Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Assessing combined anti-platelet therapy in suspected acute myocardial infarction Aspirin has been shown to be effective in the emergency treatment of acute myocardial infarction. It irreversibly inhibits platelet cyclo-oxygenase and thereby prevents the formation of the platelet aggregating agent t...
Egile nagusia: | Second Chinese Cardiac Study (CCS-2) Collaborative Group |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2000
|
Antzeko izenburuak
-
COMMIT/CCS-2 Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study
nork: Collins, R
Argitaratua: (2005) -
COMMIT/CCS-2 (Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study)
nork: Chen, Z
Argitaratua: (2005) -
Gender difference in prognosis after acute MI among 45,852 Chinese patients in COMMIT/CCS2
nork: Chen, Y, et al.
Argitaratua: (2009) -
ORAL CAPTOPRIL VERSUS PLACEBO AMONG 13634 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT FROM THE CHINESE CARDIAC STUDY (CCS-1)
nork: Liu, L, et al.
Argitaratua: (1995) -
Social Acceptance of CCS
nork: Atsuko TANAKA
Argitaratua: (2020-11-01)